pharma-company /Medicinal products /Active ingredients

Rx · PZN 13880623, 15238233, 13880652

IMANIVEC 400 mg tablets for preparation of a suspension for oral use

German trade nameIMANIVEC 400 mg Tabletten zur Herstellung einer Suspension zur Einnehmen

Active ingredientImatinib

No observed availability

0.0

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Average purchase price (B2B)

~ €278

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

This figure is an approximation across all recorded pack sizes. We are happy to advise you on your terms for IMANIVEC 400 mg tablets for preparation of a suspension for oral use.

Review purchasing terms

IMANIVEC 400 mg tablets for preparation of a suspension for oral use contains the active ingredient Imatinib. 3 pack sizes of this product are recorded. All packs reach a pharma availability index of 0.0 out of 10 over the past 30 days.


Pack sizes · 3 PZN

PZNIndex 7 dIndex 30 d Highest known purchase price
138806230.00.0~ €139
152382330.00.0N/A
138806520.00.0~ €417

IMANIVEC 400 mg tablets for preparation of a suspension for oral use was not procurable through German pharmaceutical wholesale in the past 30 days. We help you identify sources of supply, import routes and alternative products.

Request a source of supply

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. The average purchase price was calculated across 2 of 3 PZNs.